|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2008-9-1
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) bone substudy assesses zoledronic acid for preventing bone loss associated with adjuvant endocrine therapy and reports on long-term findings of bone-mineral density (BMD) during 3 years of treatment and 2 years after completing adjuvant treatment with or without zoledronic acid. The aim of this substudy is to gain insight into bone health in this setting.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles,
http://linkedlifedata.com/resource/pubmed/chemical/anastrozole,
http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1474-5488
|
|
pubmed:author |
pubmed-author:Austrian Breast and Colorectal Cancer Study Group (ABCSG),
pubmed-author:Bjelic-RadisicVesnaV,
pubmed-author:DubskyPeterP,
pubmed-author:FitzalFlorianF,
pubmed-author:GnantMichaelM,
pubmed-author:GreilRichardR,
pubmed-author:JakeszRaimundR,
pubmed-author:KässmannHelmutH,
pubmed-author:KainbergerFranzF,
pubmed-author:KubistaErnstE,
pubmed-author:Luschin-EbengreuthGeroG,
pubmed-author:MarthChristianC,
pubmed-author:MenzelChristianC,
pubmed-author:MittlböckMartinaM,
pubmed-author:MlineritschBrigitteB,
pubmed-author:Piswanger-SölknerJutta ClaudiaJC,
pubmed-author:PlonerFerdinandF,
pubmed-author:SamoniggHellmutH,
pubmed-author:SeifertMichaelM,
pubmed-author:StegerGüntherG,
pubmed-author:WohlmuthPeterP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
840-9
|
|
pubmed:dateRevised |
2009-3-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18718815-Adult,
pubmed-meshheading:18718815-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18718815-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18718815-Bone Density,
pubmed-meshheading:18718815-Bone Density Conservation Agents,
pubmed-meshheading:18718815-Bone Diseases, Metabolic,
pubmed-meshheading:18718815-Breast Neoplasms,
pubmed-meshheading:18718815-Chemotherapy, Adjuvant,
pubmed-meshheading:18718815-Diphosphonates,
pubmed-meshheading:18718815-Female,
pubmed-meshheading:18718815-Goserelin,
pubmed-meshheading:18718815-Humans,
pubmed-meshheading:18718815-Imidazoles,
pubmed-meshheading:18718815-Linear Models,
pubmed-meshheading:18718815-Nitriles,
pubmed-meshheading:18718815-Osteoporosis,
pubmed-meshheading:18718815-Premenopause,
pubmed-meshheading:18718815-Prospective Studies,
pubmed-meshheading:18718815-Tamoxifen,
pubmed-meshheading:18718815-Triazoles
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
|
|
pubmed:affiliation |
Department of Surgery, Medical University of Vienna, General Hospital Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
